We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Coca-Cola Europacific Partners
CCEP
$46.9B
| $145M | 0.18% |
2,811,331
-125,311
| -4% | -$5.95M |
|
127
StoneCo
STNE
$2.73B
| $144M | 0.18% |
3,491,865
+897,225
| +35% | +$24.4M |
|
128
Arrowhead Research
ARWR
$12.8B
| $143M | 0.18% |
7,803,131
-2,951
| -0% | -$48.7K |
|
129
Prudential Financial
PRU
$41.3B
| $143M | 0.18% |
1,554,721
+7,894
| +0.5% | +$728K |
|
130
Abbott
ABT
$175B
| $142M | 0.18% |
1,780,605
-482,962
| -21% | -$35.9M |
|
|
BLUE
131
DELISTED
bluebird bio
BLUE
| $140M | 0.17% |
68,920
+6,594
| +11% | +$11.6M |
|
132
Medtronic
MDT
$105B
| $138M | 0.17% |
1,520,155
+746,546
| +97% | +$66.8M |
|
133
SLB Ltd
SLB
$71.1B
| $137M | 0.17% |
3,149,777
-1,298,896
| -29% | -$56.1M |
|
|
BPMC
134
DELISTED
Blueprint Medicines
BPMC
| $137M | 0.17% |
1,710,895
+5,720
| +0.3% | +$423K |
|
135
Walmart Inc
WMT
$866B
| $136M | 0.17% |
4,194,243
+74,805
| +2% | +$2.43M |
|
136
Westlake Chemical Partners
WLKP
$775M
| $135M | 0.17% |
5,950,074
-97,792
| -2% | -$2.23M |
|
137
Cintas
CTAS
$80B
| $132M | 0.16% |
2,613,628
+2,014,988
| +337% | +$97.6M |
|
|
SMC
138
Summit Midstream
SMC
$416M
| $132M | 0.16% |
903,274
+4,683
| +0.5% | +$824K |
|
|
FTCH
139
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $130M | 0.16% |
4,814,650
+18,860
| +0.4% | +$423K |
|
140
HUTCHMED
HCM
$1.92B
| $129M | 0.16% |
4,207,823
-58,120
| -1% | -$1.45M |
|
141
McDonald's
MCD
$188B
| $127M | 0.16% |
667,545
-51,565
| -7% | -$9.36M |
|
|
142
Pinduoduo
PDD
$119B
| $125M | 0.16% |
5,049,681
-10,840,389
| -68% | -$291M |
|
143
Labcorp
LH
$22.9B
| $124M | 0.15% |
946,077
-107,386
| -10% | -$13.2M |
|
144
Eastman Chemical
EMN
$8B
| $122M | 0.15% |
1,611,449
-605,592
| -27% | -$48.1M |
|
145
LivaNova
LIVN
$4.31B
| $119M | 0.15% |
1,226,392
-4,714
| -0.4% | -$440K |
|
|
SHLX
146
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $118M | 0.15% |
5,754,685
+3,129,607
| +119% | +$60.1M |
|
147
NVIDIA
NVDA
$5.19T
| $117M | 0.15% |
26,139,000
+12,847,720
| +97% | +$49.9M |
|
148
IBM
IBM
$195B
| $115M | 0.14% |
849,699
+102,822
| +14% | +$13.1M |
|
149
Biogen
BIIB
$29.6B
| $112M | 0.14% |
472,260
-318,818
| -40% | -$100M |
|
150
PTC
PTC
$13.1B
| $111M | 0.14% |
1,203,691
-119,978
| -9% | -$10.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.